Your session is about to expire
← Back to Search
Peer Coaching for Cardiovascular Disease Risk Reduction (RePeAT Trial)
N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-coaching, approximately 1-2 weeks prior to the patient-clinician office visit
Awards & highlights
RePeAT Trial Summary
This trial will explore if peer-coaches can help those with limited health literacy make informed decisions about reducing cardiovascular disease risk.
Who is the study for?
The RePeAT trial is for English-speaking adults aged 40-75 who are patients at Highland Family Medicine, have limited health literacy, and a ≥10% risk of cardiovascular disease. They must plan to stay with the practice for at least a year and be able to consent.Check my eligibility
What is being tested?
This study tests if peer-coaches can help patients with low health literacy make informed decisions about reducing their risk of heart disease. It's about training peers to support these patients in understanding their choices.See study design
What are the potential side effects?
Since this trial involves education and coaching rather than medication or medical procedures, there are no direct side effects related to drugs or surgical interventions.
RePeAT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-coaching, approximately 1-2 weeks prior to the patient-clinician office visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-coaching, approximately 1-2 weeks prior to the patient-clinician office visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ABCS Discussion
Secondary outcome measures
Peer Coach Fidelity
RePeAT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Peer CoachExperimental Treatment1 Intervention
The research coordinator will set up a time for the subject to have a brief discussion with a peer coach from the study team approximately 1 week after randomization. During the coaching session, the peer coach will encourage the subject to mention their heart health goals to their primary care clinician during their next primary care appointment. The peer coach will also help the subject brainstorm ways to remove any barriers that may prevent them from having the discussion with their clinician. The peer coaching session and the subsequent medical appointment will be audio-recorded.
Group II: ControlActive Control1 Intervention
The subject will not be asked to meet with the peer coach or anyone from the study team prior to their next visit with their primary care clinician. Their subsequent primary care appointment will be audio-recorded.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer Coach
2017
N/A
~1600
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,835 Previous Clinical Trials
47,310,582 Total Patients Enrolled
University of RochesterLead Sponsor
837 Previous Clinical Trials
518,092 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a heart attack, stroke, or a procedure like stent placement.I am unable to understand or make decisions about my treatment.My risk for cardiovascular disease is 10% or higher.I have a condition affecting the blood flow to my limbs.I speak English.I am between 40 and 75 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Peer Coach
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Am I eligible to partake in this medical experiment?
"Qualified candidates for this clinical trial should possess coronary heart disease and be between 40 to 75 years old. Currently, the study is attempting to recruit a total of 60 participants."
Answered by AI
Does this clinical trial admit minors to participate?
"According to the criteria listed in this trial, patients aged 40-75 are eligible for submission. 32 studies call for participants under 18 and 399 require those older than 65 years of age."
Answered by AI
Are there any vacancies in the current clinical trial?
"Contrary to what is seen in clinicaltrials.gov, this research project has stopped enrolling new participants as of June 27th 2023. The original posting date for the study was September 1st 2021. Despite no longer recruiting patients here, 446 other trials are welcoming candidates at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger